<DOC>
	<DOCNO>NCT01661127</DOCNO>
	<brief_summary>Psoriasis associate increase marker inflammation skin blood increasingly think systemic inflammatory disease risk factor incident diabetes mellitus , myocardial infarction , stroke , premature cardiovascular death . Furthermore , important clinician aware psoriasis substantial emotional impact individual , necessarily relate extent skin disease . FDG-PET/CT represent innovative approach study systemic inflammation manner sensitive , quantifiable , anatomically localizable . Also , recent study show chronic disease end stage renal disease depressive symptom decrease cerebral glucose metabolism several brain area F-18-FDG PET/CT . So protocol design evaluate usefulness PET/CT detect systemic inflammation abnormality cerebral glucose metabolism association metabolic syndrome/major depressive symptom patient psoriasis .</brief_summary>
	<brief_title>Clinical Study PET/CT Association With Metabolic Syndrome/Depressive Symptoms Psoriasis</brief_title>
	<detailed_description>10 Patients psoriasis 1 . Evaluate PASI score 2 . Evaluate comorbidity metabolic syndrome - Body mass index ( BMI ) - Checking blood pressure - Checking blood sugar - Smoking drink history - Checking blood cholesterol level - Risk factor cardiovascular disease 3 . PET/CT measure extent site psoriasis inflammation</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>Histological diagnosis plaque type psoriasis least 18 year old understand questionnaire take antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>